Uncategorized
Arcus Biosciences Inc. (NYSE: RCUS) Gets A 50.46% Target Price Upside From Analysts While 21.33% Above Its 52-Week Low
Arcus Biosciences Inc. (NYSE:RCUS) does about 1.18M shares in volume on a normal day but saw 853343 shares change hands